Voloridge Investment Management, LLC Xencor Inc Transaction History

Voloridge Investment Management, LLC

  • $26.2 Billion
  • Q3 2024

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
BUY
$18.65 - $26.52 $1.95 Million - $2.77 Million
104,404 New
104,404 $2.31 Million
Q2 2022

Aug 15, 2022
BUY
$19.74 - $29.01 $28,129 - $41,339
1,425 Added 4.51%
33,007 $903,000
Q1 2022

May 16, 2022
BUY
$26.68 - $41.63 $842,607 - $1.31 Million
31,582 New
31,582 $843,000
Q4 2021

Feb 14, 2022
SELL
$33.67 - $43.44 $621,278 - $801,554
-18,452 Closed
0 $0
Q3 2021

Nov 15, 2021
SELL
$30.65 - $35.68 $66,755 - $77,711
-2,178 Reduced 10.56%
18,452 $603,000
Q2 2021

Aug 16, 2021
BUY
$34.33 - $44.68 $708,227 - $921,748
20,630 New
20,630 $712,000

Others Institutions Holding XNCR

# of Institutions
214
Shares Held
71.8M
Call Options Held
2.5K
Put Options Held
7.9K
View Full List

About Xencor Inc

XNCR Quotes by TradingView
  • Ticker XNCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,698,100
  • Market Cap $1.09B
  • Description
  • Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...
More about XNCR
Track This Portfolio

Track Voloridge Investment Management, LLC Portfolio

Follow Voloridge Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voloridge Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voloridge Investment Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email